MedPath
NMPA Approval

Oseltamivir Phosphate for Suspension

国药准字H20253530

March 4, 2025

Drug Information

磷酸奥司他韦干混悬剂

口服混悬剂

0.36g(按C₁₆H₂₈N₂O₄ 计)

化学药品

March 4, 2025

Company Information

Applicant Company

深圳市龙华新区观澜高新园区澜清一路16号

Manufacturing Company

湖北省武汉经济技术开发区海特科技园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸奥司他韦干混悬剂 - NMPA 批准文号 | MedPath